ArticleProbiotics and antimicrobial proteins2026
Mitigating Cadmium Toxicity: The Therapeutic Potential of Lactobacillus acidophilus Pro4 in Mice.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Combatting Cadmium Toxicity in Animals with Nature-Derived Remedies: Mechanisms and Mitigation.Biological trace element research · 2026Review
- Effects of heavy metal exposure on kidney transplant recipients: mechanisms and clinical implications for graft failure risk.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cadmium (Cd) is a highly toxic heavy metal known to negatively impact multiple bodily systems. This study investigated the effectiveness of Lactobacillus acidophilus Pro4, a probiotic strain isolated from natural pickles, as an anti-cadmium toxicity supplement. Forty male albino mice were divided into five groups: the control group (C), the probiotic group (Pro4), the cadmium group (Cd), the protective group (Pr), and the therapy group (Th). The body weight, liver functions, and tissue pathology of liver and the expression of IGF1, GH, GH1, and GHR1 genes were assessed. Cadmium exposure significantly impacted the mice, reducing their daily weight gain and causing liver damage. This was evident by elevated levels of GOT and GPT enzymes in the serum, along with signs of degeneration in the liver tissue, and downregulation of the expression of IGF1, GH, GH1, and GHR1 genes compared to the control group. Mice in the Pro4 group displayed increased daily weight gain and the expression of IGF1, GH, GH1, and GHR1 genes compared to other groups. While GOT levels decreased significantly compared to the control group, GPT levels remained unchanged. Liver tissue appeared mostly normal, with a slightly dilated central vein and some inflammatory cells. In the Th group, the results were encouraging but not a complete reversal of damage. Levels of GOT and GPT enzymes improved compared to the cadmium-only group, and the liver tissue showed signs of repair. Therefore, the novel Lactobacillus acidophilus Pro4 offers a promising approach to mitigate the adverse effects of cadmium on growth in mice by improving weight gain and regulating biochemical markers.
Indexed as
Identifiers
40423875What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.